Celsius Therapeutics
Celsius Therapeutics is a biotechnology company focused on developing precision medicines for immuno-inflammatory diseases using single-cell RNA sequencing and machine learning.
Services
Celsius Therapeutics focuses on developing precision medicines for inflammatory diseases. By leveraging single-cell RNA sequencing, they aim to produce targeted therapies. Their services are centered around understanding complex cellular programs in immuno-inflammatory conditions, such as inflammatory bowel disease. The company’s use of machine learning and single-cell genomics enables the identification of new therapeutic targets and patient subgroups, advancing the field of precision medicine.
Products
Celsius Therapeutics is in the process of developing several precision therapies. Their primary product in development is an anti-TREM1 antibody designed for the treatment of inflammatory bowel disease. This candidate was identified through a combination of machine learning and clinical sample analysis, showcasing their innovative approach to precision medicine. The company’s product pipeline focuses on harnessing cellular insights to create targeted treatments for complex immuno-inflammatory diseases.
Technology and Innovation
The core technology used by Celsius Therapeutics is harnessing single-cell RNA sequencing, machine learning, and the SCOPE platform. This platform allows for the in-depth analysis of cellular programs, generating novel insights into disease biology. With the ability to analyze five million cells and generate 100 billion gene expression data points, their technology translates complex biological data into actionable therapeutic targets. This approach aims to revolutionize the development of precision medicine for inflammatory diseases.
Headquarters
Celsius Therapeutics is headquartered in Cambridge, Massachusetts, specifically at 245 First Street, 18th Floor, Cambridge, MA 02142. This location places the company at the heart of a major biotechnology hub, fostering collaboration and innovation within the field. The headquarters serves as the central hub for their research, development, and strategic operations focused on advancing precision medicine for inflammatory diseases.